https://www.selleckchem.com/pr....oducts/anlotinib-al3
005 and p = 0.048, respectively). CONCLUSION nivolumab in R/M HNSCC is burdened with a high early progression rate. Previous wide neck dissection and high dose radiotherapy may compromise the efficacy of nivolumab, distorting the anatomy of the local lymphatic system and hindering the priming of immune response.This paper presents a rotating focused field eddy-current (EC) sensing technique, which leverages the advantages of magnetic field focusing and rotating magnetic field, for arbitrary orientation defects detection. The se
Like
Comment
Share
